Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When does this "power hour" that I keep hearing so much about start?
TIA
Looking at the trading it doesn't seem to be quite there yet. EM
Guess 41 is support. em
Here are all the trades in 2014.
$0.003 6 OTO 09:48:14
$0.003 500 OTO 01/22
$0.004 20,000 OTO 01/22
$0.003 2 OTO 01/21
$0.003 35,000 OTO 01/21
$0.003 10,000 OTO 01/21
$0.0025 200,000 OTO 01/21
$0.005 4,998 OTO 01/16
GLTU
I am waiting for this site to come online. http://www.evolveusacharging.com/
I think it is called Dilution. EM
Is it getting any clearer? EM
TIMBERRR.... EM
Lot Size my friend. Depends on how many shares you want and how much commission you are going to pay day after day with tiny nibbles on your bid.
I have never seen a more amateur seller then the one that has been here the last couple of weeks. They under cut the ask by more than one tick. Completely just giving away profit IMO. Or maybe increasing their loss.
GLTY
They have to dilute as they have no cash. IMO wait for that to finish and see where the company is at after. Buying now is suicide.
Isn't the d on the end of the ticker for bankruptcy?
Glta
Get them while they are cheap!! EM :)
Odd size lots... JNSH
$0.0119 300 OTO 14:45:33
$0.0124 100,000 OTO 14:36:47
$0.0123 60,920 OTO 14:35:05
$0.0123 300 OTO 13:51:46
$0.0124 300 OTO 13:28:30
$0.012 35,000 OTO 13:02:21
$0.0115 10,000 OTO 12:54:34
$0.0115 30,000 OTO 12:52:18
$0.0114 80,000 OTO 12:51:18
$0.0113 28,500 OTO 12:49:16
$0.0115 20,000 OTO 11:21:29
$0.0119 10,000 OTO 10:44:50
$0.0105 80,000 OTO 10:44:15
$0.0106 80,000 OTO 10:44:08
$0.012 35,000 OTO 09:37:31
I am a mind reader. EM
Someone is selling and keeps lowering the ask - for the last couple of days. Once they are gone up we go. .012+ with zero trades.
GLTY
I like your style. Member marked. GLTY.
I got it now. TY.
Wow. That's not misleading at all. Anyway GLTY.
OTC is OCt 1st. SOS is oct 31.
I am done with this issue.
And as of October 31 SOS Says 500 mill AS. Your information is outdated.
https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=246200068020130096088145135249153182130152129003
Registered Agent: 007 Agents, Inc. Agent Address: 1876 Horse Creek Rd
Cheyenne, WY 82009 USA
Latest AR/Year: 01891385 / 2013
AR Exempt: N License Tax Paid: $50.00
Preferred Shares: Preferred Par Value:
Common Shares: 500,000,000 Common Par Value: $0.001
May being the correct word. No one has any proof either way. History does tend to repeat itself though.
GLTY
They did it on the last run when they sold shares at a huge discount to some group. Forget the name. But they made a killing on that deal.
That is not accurate they raised to 500 check the SOS.
https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=246200068020130096088145135249153182130152129003
Timberrrrrrr.....
I am a nubie here. I will catch on. :)
This one. They never delivered the goods. Back in court over it.
http://ih.advfn.com/p.php?pid=nmona&article=59364892
Here is some more recent updates.
http://www.jnsholdings.com/press-releases.php
GLTY
Holding through the weekend? I don't think so. EM
Baggies in the making. EM
A lot of people stepping on each other to sit on the bid. EM
I have been watching this one for a while now. Not sure if I should wait for news to jump in or try to collect a few sub penny.
I live in Chicago as well which is another reason I am drawn to this stock.
GL
I am willing to sell at a quarter. EM
Calm before the storm.. EM
The only thing falsified was the part about an SEC investigation over one PR.... Laughable... HA HA HA...
I wouldn't get to upset till this passes 0055... EM
ITs Moving...
Accumulation! EM.
NEWS.
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra"
TORONTO, ON--(Marketwired - Dec 11, 2013) - Easton Pharmaceuticals (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic healthcare products provides update towards its 2 main initiatives, its minority ownership interest for its early stage cancer drug "Xilive" and on its Mexican government regulatory filing For Its "Viorra" product.
The Company is attempting to allocate its financial resources in the most cost effective manner possible. As a result of the company's recent purchase of its minority ownership interest in its early stage Cancer Drug "Xilive" and the positive feedback received, Easton Pharmaceuticals has shifted its main focus towards "Xilive" and initiating some form of early stage clinical trial testing program as well as continuing with its government approval process for "Viorra" in Mexico and other Latin American countries. Easton Pharmaceuticals has initiated discussions with both in-house consultants as well as third parties who have prior knowledge and experience with bringing such a testing program forward with both the FDA and within other countries such as Mexico and Canada. Due to cost and regulatory reasons, the Company and the current majority owners of its cancer drug "Xilive" believe the best course of action for "Xilive" is to attempt to initially enter into some form of testing protocol outside of the United States prior to entering into more expensive FDA recognized clinical trials in the United States. The Company believes its best to initially focus towards other jurisdictions such as Mexico, Canada, Italy, Germany and various other countries including China where costs are deemed greatly reduced and regulations are considered quicker, much less stringent and more favorable towards allowing the use of early stage cancer drugs such as "Xilive" to be utilized on prospective Cancer patients in controlled trials. Although certain states in the United States allow for the use of experimental cancer Drugs on compassionate grounds, such drugs would still fall under the regulations of the Food and Drug Administration which will require some type of approval process prior to being used on any prospective patients. Countries such as Canada and certain Provinces such as B.C. have less regulated processes and allow for the use of early stage drugs to be used under certain exemptions and circumstances. However, various countries such as Mexico and other European countries, namely Germany and Italy are considered the most open towards allowing the use of early stage experimental cancer drugs such as "Xilive" and other treatments. The company is presently attempting to develop relationships with certain cancer clinics and physicians as well as patients from North America who currently travel to these countries for treatments. It is estimated that each year many thousands of individuals suffering from cancer travel to these countries for treatments, which are not available in the United States.
In other initiatives, through its consultants in Mexico, Easton Pharmaceuticals believes it is close to sourcing out a manufacturing and distribution partners in Mexico for its "Viorra" product. Such manufacturing partners are considered FDA certified facilities as well as being more cost effective than if it was manufactured in the United States or Canada. BMV, the companies consultants in Mexico who are presently spearheading the regulatory and filing process in Mexico strongly believes the company could gain government approval within the first half of 2014 where sales through a distributor being sourced out by BMV will commence shortly thereafter. The companies updated website is expected to be brought online shortly where certain products can initially be purchased by consumers in North America. It is currently in the process of manufacturing a large batch of its final version of "Viorra."
About Easton Pharmaceuticals Inc.
Easton Pharmaceuticals is a specialty pharmaceutical company that owns, designs, develops, and markets topically-delivered Drugs and therapeutic healthcare products, focused on Cancer and other health issues related to male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company's gel formulation is thought to be an innovative and unique transdermal delivery system. Easton Pharmaceuticals product "VIORRA," is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder) the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients.
For More Information Visit http://www.eastonpharma.com & http://www.ashleybiomedical.com
Safe Harbor
Hopefully we will not be getting coal in our stockings this year.
0.0016152019002375 per share. If they were sold into the run they made a pretty hefty profit.
Office:
http://www.eastonpharma.com/index.php/contact.html
Toronto: 416-619-0291 New York: 347-284-0192
Media Relations: Media@eastonpharma.com
Investor Relations: IR@eastonpharma.com
Product Information: PI@eastonpharma.com
Human Resources: HR@eastonpharma.com
Sure seems to be a lot of trading going on for a week when no one is supposed to be paying attention.
The timing of this just doesn't add up for me.
GLTY
L6